AVRICORE HEALTH INC (AVCR.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:AVCR - CA0545211090 - Common Stock
AVCR.CA Key Statistics, Chart & Performance
The current stock price of AVCR.CA is 0.05 CAD. In the past month the price decreased by -9.09%. In the past year, price decreased by -16.67%.
AVCR.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VHI.CA | VITALHUB CORP | 157.83 | 597.75M | ||
| NURS.CA | HYDREIGHT TECHNOLOGIES INC | 473 | 234.56M | ||
| KDA.CA | KDA GROUP INC | N/A | 46.67M | ||
| ADK.CA | DIAGNOS INC | N/A | 38.63M | ||
| EKG.CA | CARDIOCOMM SOLUTIONS INC | N/A | 1.97M |
Related stock screener links
About AVCR.CA
Company Profile
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.
Company Info
AVRICORE HEALTH INC
1120 - 789 West Pender Street
Vancouver BRITISH COLUMBIA V7X 1H7 CA
CEO: Hector Bremner
Employees: 0
Phone: 16047738943
AVRICORE HEALTH INC / AVCR.CA FAQ
What does AVCR do?
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.
Can you provide the latest stock price for AVRICORE HEALTH INC?
The current stock price of AVCR.CA is 0.05 CAD.
What is the dividend status of AVRICORE HEALTH INC?
AVCR.CA does not pay a dividend.
What is the ChartMill rating of AVRICORE HEALTH INC stock?
AVCR.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for AVRICORE HEALTH INC?
AVRICORE HEALTH INC (AVCR.CA) operates in the Health Care sector and the Health Care Technology industry.
How many employees does AVRICORE HEALTH INC have?
AVRICORE HEALTH INC (AVCR.CA) currently has 0 employees.
AVCR.CA Technical Analysis
AVCR.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA. While AVCR.CA has a great health rating, there are worries on its profitability.
AVCR.CA Financial Highlights
Over the last trailing twelve months AVCR.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -1820% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -122.49% | ||
| ROE | -125.89% | ||
| Debt/Equity | 0 |